Parkinson's disease (PD) and atypical Parkinsonian syndromes are progressive
heterogeneous neurodegenerative diseases that share clinical characteristic of …

Two centuries ago in 1817, James Parkinson provided the first medical description of
Parkinson's disease, later refined by Jean-Martin Charcot in the mid-to-late 19th century to …

ABSTRACT PSP is a pathologically defined neurodegenerative tauopathy with a variety of
clinical presentations including typical Richardson's syndrome and other variant PSP …

Background and objectives The last version of the EFNS dementia guidelines is from 2007.
In 2010, the revised guidelines for Alzheimer's disease (AD) were published. The current …

Objectives: We performed a systematic review to assess alterations in measures of diffusion
tensor imaging (DTI) in parkinsonian syndromes, exploring the potential role of DTI in …

Conventional single tensor diffusion analysis models have provided mixed findings in the
substantia nigra of Parkinson's disease, but recent work using a bi-tensor analysis model …

Objective: To use diffusion tensor imaging (DTI) to assess gray matter and white matter tract
diffusion in behavioral variant frontotemporal dementia (bvFTD), semantic dementia (SMD) …

Objective We applied diffusion‐tensor imaging (DTI) including measurements of mean
diffusivity (MD), a parameter of brain tissue integrity, fractional anisotropy (FA), a parameter …

Corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP) represent
challenging neurodegenerative disorders for clinicians and nonclinical scientists alike …

Neurodegenerative disorders leading to dementia are common diseases that affect many
older and some young adults. Neuroimaging methods are important tools for assessing and …